Glaxosmithkline Pharmaceuticals

GLAXO

₹ 2,829.73

₹ 14.52

0.51%

Modeled data

Glaxosmithkline Pharmaceuticals
Market Sentiment

Timeline	Returns	Volume
Daily	0.51	48,221
Weekly	0.96%	1,65,189
Monthly	2.14%	13,69,467

Glaxosmithkline Pharmaceuticals
Performance

Timeline	Daily	Weekly	Monthly
GLAXO	0.51	0.96%	2.14%
Index	-	-	-
Peer Avg.	-0.00%	2.70%	13.69%

*Avg of index constituents

Glaxosmithkline Pharmaceuticals
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
GLAXO	45.72	10.55	24.95	18.21	37.43	6.88
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	38.60	4.35	13.48	12.96	16.49	0.78

*Avg of index constituents

Glaxosmithkline Pharmaceuticals
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	11.11%	31.95%	18.21%	37.43%
FY '20-21	-9.35%	184.36%	17.30%	27.55%
FY '19-20	3.08%	-76.60%	5.12%	16.13%

Glaxosmithkline Pharmaceuticals
Shareholding Pattern

Promoters : 75%

FII : 2.18%

DII : 10.73%

Public : 12.09%

Others : 0%

Glaxosmithkline Pharmaceuticals
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	3,247.77	2,488.92	834.85	378.67
FY '20-21	2,923.04	2,325.08	708.34	286.98
FY '19-20	3,224.53	2,566.68	736.13	101.63

All values are in crores

Glaxosmithkline Pharmaceuticals
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
GLAXO	3,247.77	2,488.92	834.85	378.67
IPCALAB	5,581.70	4,357.43	1,341.09	890.95
GLAND	4,400.71	2,890.31	1,734.33	1,211.91

All values are in crores

Glaxosmithkline Pharmaceuticals Share Price

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company's field of activity is the production, distribution and trade of medicines. It produces drugs used in the pharmaceutical industry, such as antibiotics, endocrine products, essential vitamins; opium derivatives; sulfa drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and plant alkaloids and chemically pure sugar. It offers a variety of prescription drugs, vaccines and consumer health products. Its drug portfolio includes Adartrel, Bactroban, Combodart and Duodart. Its vaccine portfolio includes Ambirix, Cervarix, Fendrix and Havrix. The company's products include betamethasone, clavulanate potassium with amoxicillin, and pneumococcal polysaccharide and conjugate vaccine. Its oral care products include Sensodyne, parodontax and Polident. Its manufacturing unit is located in Nashik.

Glaxosmithkline Pharmaceuticals FAQs

How to Buy Glaxosmithkline Pharmaceuticals Share?

To purchase Glaxosmithkline Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) on the trading platform provided by your broker and purchase the shares.

What's Glaxosmithkline Pharmaceuticals share price today?

The stock price of Glaxosmithkline Pharmaceuticals as of 13 Sep 2024 is ₹2,829.73

What is the Market Cap of Glaxosmithkline Pharmaceuticals?

Market capitalisation represents the total market value of a company's outstanding shares. As of 13 Sep 2024, Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) has a market capitalisation of approximately ₹2,21,54,92,11,265.20

What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals?

Glaxosmithkline Pharmaceuticals Ltd's price-to-book ratio as of 13 Sep 2024 is 10.550022, reflecting the market's valuation compared to its asset value. As of 13 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 45.71615, indicating the market values the company at around ₹45.72 for every ₹1 of earnings